Why investing in immunization means investing in a healthier future
Pauline brought her son, Louis, for his measles vaccination three times in the Democratic Republic of Congo. Each time, she returned home without her son receiving the vaccine. Uncertain supplies meant that a vaccine’s protection remained out of reach, even when families came seeking it; Pauline wanted to protect her child, but that isn’t always enough.
A vaccine can only do its job when families can access it. That depends on reliable supplies, trusted information and health services that are available when people arrive.
This is why investing in immunization means more than investing in vaccines alone. It means investing in the systems that help protection reach every child and every community.
For more than two decades, VillageReach has worked alongside communities, health workers and governments to help ensure that lifesaving health services reach the people who need them. What happens when those efforts come together is changing the course of children’s lives.
More life ahead
The World Health Organization estimates that vaccination against 14 diseases saved at least 154 million lives between 1974 and 2024 — 101 million were infants. Immunization accounted for 40% of the global decline in infant deaths over that 50-year period.
Behind those numbers are millions of children who survived, and millions of families who have brighter futures.
It is also one of the most cost-effective investments in health. Research covering immunization against 10 pathogens in 94 low- and middle-income countries projected nearly $20 in net economic benefits for every $1 invested during 2021–2030. Preventing illness spares treatment expenses and time away from work, while reducing demands on health services.
But there is work still to do. In 2025, 13.5 million infants did not receive a first dose of a vaccine against diphtheria, tetanus and pertussis — the measure used to identify “zero-dose” children. Millions of others began vaccination but missed later doses.
With all we know about the importance of immunization for a lifetime of health, why does the challenge persist?
What it takes to reach someone
To better understand why children miss vaccinations due at 9 months, VillageReach and research partners conducted 457 interviews across the Democratic Republic of Congo, Malawi, Nigeria and Pakistan. They found a mix of barriers, including unreliable services at health facilities and fewer reminders to return for vaccines as children grew older.
Listening closely changes the response. In that study, communities helped identify practical solutions: stronger reminders, clearer information on later doses and catch-up vaccination, greater involvement of other family members and more reliable services. A reminder can help when someone has lost track of a date. It cannot make up for a vaccination that is unavailable when they arrive.
VillageReach’s wider work in the DRC shows how stronger follow-up can help. In Kipushi, community health worker Aimerance Mitonga met Vicky Tshibidi, whose 17-month-old daughter, Marina, had missed vaccinations. Aimerance encouraged her to visit Promesse Health Facility, where Marina received the oral polio vaccine. With Aimerance tracking her progress and following up, Vicky returned to complete her daughter’s immunization schedule.
While repeated unsuccessful visits left Pauline discouraged, Marina’s experience shows what can happen when the system works.
Access belongs at the center of the investment case. Vaccine science and dependable services work together. Communities help identify what needs to change; health teams and governments help make those changes part of everyday care.
Protection across a lifetime
While routine childhood vaccines are fundamental to helping a child’s survival, immunization continues to be important throughout the lifetime.
HPV vaccination is an especially powerful example because it effectively prevents most types of cervical cancer. While cervical cancer is highly treatable, in under-reached communities, it’s often undiagnosed; 70,000 women in Africa die each year from cervical cancer. However, a recently published study followed girls and women for up to 18 years: those vaccinated before age 17 had nearly 80% lower risk of invasive cervical cancer than those who were unvaccinated.
VillageReach is supporting HPV vaccination programs in Nigeria, Malawi and Mozambique, including by helping health workers and community advocates bring information to families. In Mozambique, Verónica Chimoio, a mother of eight and a trusted community educator, gained practical tools and new knowledge through VillageReach’s HPV training. Days later, she was putting them to use at her community’s water point, where she spoke with teenagers, women and men about HPV vaccination, screening and where to seek care. Illustrated materials helped her reach neighbors who could not read.
Protecting an adolescent with HPV vaccination prevents infection now and lowers her risk of cervical cancer in the future. Women like Verónica help the next generation access that protection.
Your support helps VillageReach work with communities, health workers and governments to make health care more accessible. Immunization shows what is possible when effective prevention reaches everyone.